• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普鲁卡因酰胺亚治疗水平对缺氧心肌细胞的电生理效应(作者译)

[Electrophysiological effects of subtherapeutic levels of procainamide on hypoxic myocardial cells (author's transl)].

作者信息

Adamantidis M M, Rouet R H, Duriez P R, Vincent A C, Dupuis B A

出版信息

J Pharmacol. 1982 Jan-Mar;13(1):31-42.

PMID:7070098
Abstract
  1. The electrophysiological effects of hypoxia alone or combined with subtherapeutic concentrations of procainamide superfusion were investigated in guinea-pig ventricular muscle fibres in order to elucidate the procainamide activity on suffering myocardial cells. 2. A first 30 minute-long hypoxia depressed action potential characteristics but never induced cellular inexcitability. These alterations were entirely reversible. A second consecutive hypoxia period similarly affected cellular activity. 3. After a control hypoxia period, procainamide 0.15 microM and 1.5 microM further depressed or abolished the hypoxia-altered transmembrane potentials. 4. In procainamide 0.15 microM and 1.5 microM pretreated cells, hypoxia more extensively depressed or abolished the myocardial cell activity than in unpretreated cells. 5. It has been demonstrated that antiarrhythmic drugs only slowly and incompletely reached the ischaemic myocardium. The present results suggest that in clinical situations, such weak concentrations may be efficient for inducing pronounced modifications in ischaemic areas and rapid antiarrhythmic effects.
摘要
  1. 为阐明普鲁卡因酰胺对受损心肌细胞的作用,研究了单独缺氧或缺氧与亚治疗浓度的普鲁卡因酰胺灌注相结合对豚鼠心室肌纤维的电生理效应。2. 首个持续30分钟的缺氧期会降低动作电位特征,但从未导致细胞失去兴奋性。这些改变完全可逆。第二个连续的缺氧期同样影响细胞活性。3. 在对照缺氧期后,0.15微摩尔/升和1.5微摩尔/升的普鲁卡因酰胺进一步降低或消除了缺氧改变的跨膜电位。4. 在经0.15微摩尔/升和1.5微摩尔/升普鲁卡因酰胺预处理的细胞中,缺氧比未预处理的细胞更广泛地降低或消除了心肌细胞活性。5. 已证明抗心律失常药物只能缓慢且不完全地到达缺血心肌。目前的结果表明,在临床情况下,如此低的浓度可能有效地在缺血区域引起明显的改变并产生快速的抗心律失常作用。

相似文献

1
[Electrophysiological effects of subtherapeutic levels of procainamide on hypoxic myocardial cells (author's transl)].普鲁卡因酰胺亚治疗水平对缺氧心肌细胞的电生理效应(作者译)
J Pharmacol. 1982 Jan-Mar;13(1):31-42.
2
[Effects of nicardipine on electrophysiologic alterations and enzyme leakage induced in vitro in the guinea pig].[尼卡地平对豚鼠体外诱导的电生理改变和酶泄漏的影响]
J Pharmacol. 1985 Jan-Mar;16(1):75-90.
3
[Selective depressant effects of procainamide on the depolarized cells (author's transl)].
Kokyu To Junkan. 1980 Dec;28(12):1409-13.
4
Rate-dependent effects of sematilide on action potential duration in isolated guinea pig ventricular myocytes.塞马替利对豚鼠离体心室肌细胞动作电位时程的频率依赖性影响。
J Pharmacol Exp Ther. 1994 Oct;271(1):302-10.
5
Effects of intracellular cesium ions on electrophysiological properties in myocardial cells.细胞内铯离子对心肌细胞电生理特性的影响。
Proc West Pharmacol Soc. 1981;24:265-9.
6
Effects of procainamide, tocainide and phenytoin on guinea pig cardiac mitochondrial ATPase activity.普鲁卡因胺、妥卡尼和苯妥英对豚鼠心脏线粒体ATP酶活性的影响。
Res Commun Chem Pathol Pharmacol. 1993 Apr;80(1):121-4.
7
Effects of gallium chloride on changes in action potentials and contraction in guinea pig ventricular muscle.氯化镓对豚鼠心室肌动作电位变化及收缩的影响。
Anticancer Res. 1996 Jan-Feb;16(1):327-32.
8
Effects of 3,6-dimethamidodibenzopyriodonium citrate on slow inward calcium current in isolated guinea pig ventricular cells.柠檬酸3,6-二甲氨基二苯并碘onium对豚鼠离体心室肌细胞慢内向钙电流的影响。
Zhongguo Yao Li Xue Bao. 1993 Jul;14(4):311-4.
9
Calcium-antagonist effects of norbormide on isolated perfused heart and cardiac myocytes of guinea-pig: a comparison with verapamil.去甲溴敌隆对豚鼠离体灌注心脏和心肌细胞的钙拮抗剂作用:与维拉帕米的比较。
Br J Pharmacol. 1997 Jan;120(1):19-24. doi: 10.1038/sj.bjp.0700876.
10
On the possible role of adenosine in the hypoxia-induced alterations of the electrical and mechanical activity of the atrial myocardium.关于腺苷在缺氧诱导的心房心肌电活动和机械活动改变中可能发挥的作用。
Arch Int Pharmacodyn Ther. 1979 Apr;238(2):283-95.